Evidence map›Paper›PMID 39499086›Full record

ArticleDisease models & mechanisms2024

Modelling quiescence exit of neural stem cells reveals a FOXG1-FOXO6 axis.

Kirsty M Ferguson, Carla Blin, Claudia Garcia-Diaz, Harry Bulstrode, Raul Bardini Bressan, Katrina McCarten, Steven M Pollard

Abstract read
In one paragraph

Article in Disease models & mechanisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kirsty M FergusonCentre for Regenerative Medicine, Institute for Regeneration and Repair and Edinburgh Cancer Research UK Centre, The University of Edinburgh, Edinburgh EH16 4UU, UK.ORCID 0000-0002-6738-5203
Carla BlinCentre for Regenerative Medicine, Institute for Regeneration and Repair and Edinburgh Cancer Research UK Centre, The University of Edinburgh, Edinburgh EH16 4UU, UK.
Claudia Garcia-DiazCentre for Regenerative Medicine, Institute for Regeneration and Repair and Edinburgh Cancer Research UK Centre, The University of Edinburgh, Edinburgh EH16 4UU, UK.
Harry BulstrodeCentre for Regenerative Medicine, Institute for Regeneration and Repair and Edinburgh Cancer Research UK Centre, The University of Edinburgh, Edinburgh EH16 4UU, UK.
Raul Bardini BressanCentre for Regenerative Medicine, Institute for Regeneration and Repair and Edinburgh Cancer Research UK Centre, The University of Edinburgh, Edinburgh EH16 4UU, UK.
Katrina McCartenCentre for Regenerative Medicine, Institute for Regeneration and Repair and Edinburgh Cancer Research UK Centre, The University of Edinburgh, Edinburgh EH16 4UU, UK.
Steven M PollardCentre for Regenerative Medicine, Institute for Regeneration and Repair and Edinburgh Cancer Research UK Centre, The University of Edinburgh, Edinburgh EH16 4UU, UK.ORCID 0000-0001-6428-0492

Funding

Cancer Research UK A17368Cancer Research UK A19680Ciência sem FronteirasUniversity of EdinburghWellcome Trust 223011
6 · The paper itself

Abstract

The molecular mechanisms controlling the balance of quiescence and proliferation in adult neural stem cells (NSCs) are often deregulated in brain cancers such as glioblastoma multiforme (GBM). Previously, we reported that FOXG1, a forebrain-restricted neurodevelopmental transcription factor, is frequently upregulated in glioblastoma stem cells (GSCs) and limits the effects of cytostatic pathways, in part by repression of the tumour suppressor Foxo3. Here, we show that increased FOXG1 upregulates Foxo6, a more recently discovered FOXO family member with potential oncogenic functions. Although genetic ablation of Foxo6 in proliferating NSCs had no effect on the cell cycle or entry into quiescence, we found that Foxo6-null NSCs could no longer efficiently exit quiescence following FOXG1 elevation. Increased Foxo6 resulted in the formation of large acidic vacuoles, reminiscent of Pak1-regulated macropinocytosis. Consistently, Pak1 expression was upregulated by FOXG1 overexpression and downregulated upon FOXO6 loss in proliferative NSCs. These data suggest a pro-oncogenic role for FOXO6, downstream of GBM-associated elevated FOXG1, in controlling quiescence exit, and shed light on the potential functions of this underexplored FOXO family member.

Indexed as

Cell ProliferationForkhead Transcription FactorsNerve Tissue ProteinsNeural Stem CellsAnimalsGlioblastomaHumansMiceModels, Biologicalp21-Activated KinasesSignal TransductionUp-RegulationForkhead Transcription FactorsFOXG1 protein, humanFoxg1 protein, mouseNerve Tissue Proteinsp21-Activated KinasesFOXG1FOXO6GlioblastomaNeural stem cellPak1Quiescence

Identifiers

PMID39499086
PMCPMC11625887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.